Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Market Analysis & Valuation

UpdatedJul 12, 2026
DataAggregated Company Financials
Companies7798
  • 7D0.8%
  • 3M9.4%
  • 1Y20.6%
  • YTD9.2%

The Information Technology sector gained 3.1% while the market remained flat over the last week. More promisingly, the market is up 21% over the past year. Earnings are forecast to grow by 18% annually.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.S. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 12 Jul 2026US$76.2tUS$24.3tUS$2.5t19.3x30.6x3.1x
Tue, 09 Jun 2026US$77.9tUS$24.3tUS$2.5t18.6x31.7x3.2x
Thu, 07 May 2026US$72.0tUS$24.1tUS$2.4t19.3x29.9x3x
Sat, 04 Apr 2026US$69.2tUS$23.7tUS$2.3t18.6x30x2.9x
Mon, 02 Mar 2026US$72.2tUS$23.7tUS$2.3t19.4x31.4x3.1x
Wed, 28 Jan 2026US$73.2tUS$23.3tUS$2.3t19.3x32.1x3.1x
Fri, 26 Dec 2025US$72.8tUS$23.2tUS$2.3t19.1x31.8x3.1x
Sun, 23 Nov 2025US$68.5tUS$23.1tUS$2.3t18.2x30x3x
Tue, 21 Oct 2025US$71.1tUS$22.7tUS$2.2t18.9x32.3x3.1x
Thu, 18 Sep 2025US$69.8tUS$22.9tUS$2.2t19.1x32x3x
Sat, 16 Aug 2025US$67.7tUS$23.0tUS$2.2t18.8x31.4x2.9x
Mon, 14 Jul 2025US$65.3tUS$22.5tUS$2.1t18.7x31.1x2.9x
Wed, 11 Jun 2025US$62.9tUS$22.5tUS$2.1t18x29.9x2.8x
Fri, 09 May 2025US$58.6tUS$22.4tUS$2.1t17.3x27.9x2.6x
Sun, 06 Apr 2025US$52.5tUS$21.9tUS$2.1t16.1x25.6x2.4x
Tue, 04 Mar 2025US$62.0tUS$21.9tUS$2.0t17.6x30.4x2.8x
Thu, 30 Jan 2025US$64.1tUS$22.1tUS$2.0t18.7x32.3x2.9x
Sat, 28 Dec 2024US$63.2tUS$22.0tUS$1.9t18.3x32.6x2.9x
Mon, 25 Nov 2024US$63.0tUS$22.0tUS$1.9t19.4x32.7x2.9x
Wed, 23 Oct 2024US$60.7tUS$21.6tUS$1.9t18.3x32.5x2.8x
Fri, 20 Sep 2024US$58.1tUS$21.5tUS$1.9t18.3x31.3x2.7x
Sun, 18 Aug 2024US$57.4tUS$21.5tUS$1.8t17.9x31.1x2.7x
Tue, 16 Jul 2024US$58.3tUS$21.3tUS$1.8t17.6x31.7x2.7x
Thu, 13 Jun 2024US$55.4tUS$21.3tUS$1.8t16.9x30.3x2.6x
Sat, 11 May 2024US$54.1tUS$21.2tUS$1.8t17.4x29.9x2.5x
Mon, 08 Apr 2024US$54.2tUS$21.1tUS$1.8t17.2x29.4x2.6x
Wed, 06 Mar 2024US$53.4tUS$21.1tUS$1.8t16.3x29x2.5x
Fri, 02 Feb 2024US$51.2tUS$21.1tUS$1.8t17x29.1x2.4x
Sun, 31 Dec 2023US$50.3tUS$21.0tUS$1.8t16.9x28.6x2.4x
Tue, 28 Nov 2023US$47.6tUS$21.1tUS$1.8t15.9x27.2x2.3x
Thu, 26 Oct 2023US$43.8tUS$21.0tUS$1.7t14.7x25.4x2.1x
Sat, 23 Sep 2023US$45.5tUS$20.9tUS$1.7t15.4x26.5x2.2x
Mon, 21 Aug 2023US$46.3tUS$20.9tUS$1.7t15.8x27.3x2.2x
Wed, 19 Jul 2023US$48.3tUS$21.0tUS$1.7t15.8x28.9x2.3x
Price to Earnings Ratio

28.9x


Total Market Cap: US$48.3tTotal Earnings: US$1.7tTotal Revenue: US$21.0tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Market Price to Earnings3Y Average 30.1x202420252026
Current Market PE
  • Investors are relatively neutral on the American market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading at a PE ratio close to its 3-year average PE ratio of 30.1x.
Past Earnings Growth
  • The earnings for American listed companies have grown 14% per year over the last three years.
  • Revenues for these companies have grown 5.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Sector Trends

Which sectors have driven the changes within the U.S. Market?

US Market0.81%
Tech3.15%
Energy3.14%
Consumer Discretionary1.45%
Financials0.048%
Telecom-0.62%
Utilities-0.67%
Consumer Staples-0.96%
Real Estate-1.08%
Industrials-1.42%
Healthcare-1.49%
Materials-2.15%
Sector PE
  • Investors favour the Healthcare sector the most for future growth even though it's trading below its 3-year average PE ratio of 65.5x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 18.1%, which is higher than its past year's earnings growth of 12.6% per year.
  • The Financials sector is the least preferred by investors for future growth, which is trading close to its 3-year average of 17.6x.
Forecasted Growth
  • Analysts are most optimistic on the Telecom sector, expecting annual earnings growth of 23% over the next 5 years.
  • This is better than its past earnings decline of 2.6% per year.
  • In contrast, the Real Estate sector is expected to see its earnings grow by 8.2% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
NVDA NVIDIAUS$210.968.3%
+US$390.7b		27.9%PE32xTech
META Meta PlatformsUS$669.2114.8%
+US$219.1b		-6.7%PE24.1xTelecom
AVGO BroadcomUS$399.9711.0%
+US$188.0b		45.8%PE64.9xTech
AAPL AppleUS$315.322.2%
+US$98.3b		49.3%PE37.8xTech
AMD Advanced Micro DevicesUS$557.897.7%
+US$65.3b		281.0%PE184.4xTech
See more

Market Insights

Header cover image
No financial statement shows what a brand is 'worth' despite it being an incredibly valuable asset for some companies. In the volatile world of social media hypes and fads, it's worth understanding what makes a true enduring brand.
Continue reading
Q-Day: The risk the market forgot to reprice

Latest News

BRK.A
US$739,750.00
Berkshire Hathaway
7D
-2.9%
1Y
3.8%
ABBV
US$248.08
AbbVie
7D
-5.0%
1Y
28.9%
GOOGL
US$357.18
Alphabet
7D
-0.8%
1Y
98.2%
AVGO
US$399.97
Broadcom
7D
11.0%
1Y
45.8%
TSLA
US$407.76
Tesla
7D
3.6%
1Y
30.1%
INTC
US$109.84
Intel
7D
-8.7%
1Y
368.8%
META
US$669.21
Meta Platforms
7D
14.8%
1Y
-6.7%
AAPL
US$315.32
Apple
7D
2.2%
1Y
49.3%
Narrative Update • Jul 11

Future profits to soar by 27% amid fierce competition

Rather than creating value by inventing better phones, Apple's lawsuit against OpenAI shows how afraid Apple is of what's happening. At best, this will slow OpenAI down a bit, but in the long run, Apple's business model is in its sights.
NVDA
US$210.96
NVIDIA
7D
8.3%
1Y
27.9%
LLY
US$1,188.58
Eli Lilly
7D
-2.1%
1Y
49.9%
Narrative Update • Jul 10

LLY: GLP-1 Franchise And Retatrutide Data Will Support Balanced Future Outlook

Analysts have nudged their price targets on Eli Lilly higher, with fair value estimates moving from about $1,218.72 to roughly $1,243.43 as they point to resilient GLP-1 obesity and diabetes franchises, along with supportive recent data and previews around Zepbound, Mounjaro, Foundayo and retatrutide. Analyst Commentary Recent research updates on Eli Lilly show a cluster of higher price targets around the GLP-1 obesity and diabetes portfolio, with Zepbound, Mounjaro, Foundayo and retatrutide at the center of the discussion.
MSFT
US$385.10
Microsoft
7D
-1.4%
1Y
-23.5%
SPCX
US$145.30
Space Exploration Technologies
7D
-10.3%
1Y
n/a
Seeking Alpha • Jul 10

SpaceX: The IPO Hype Is Fading - Why Shares' True Value May Be Less Than Half Its Market Cap

Summary SpaceX is rated Sell with a $64/share price target, citing an unsustainable $1.95t valuation and excessive 327.72x EV/aEBITDA multiple. SPCX’s growth is driven by major AI data center hosting agreements and defense contracts, but long-term AI TAM assumptions are increasingly questioned. The recent $60b Cursor acquisition and Grok 4.5 launch position SPCX for enterprise AI, yet profitability faces headwinds from launch costs and rising debt. While orbital data center ambitions and vertical integration offer upside, intensifying competition and uncertain execution challenge SPCX’s premium valuation. Read the full article on Seeking Alpha
AMD
US$557.89
Advanced Micro Devices
7D
7.7%
1Y
281.0%
BABA
US$112.33
Alibaba Group Holding
7D
16.8%
1Y
5.3%
CSCO
US$121.31
Cisco Systems
7D
7.6%
1Y
78.5%
V
US$348.97
Visa
7D
-3.6%
1Y
0.3%